Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Revenue (2019 - 2025)

Historic Revenue for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $63.3 million.

  • CureVac's Revenue fell 8833.26% to $63.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year decrease of 8638.13%. This contributed to the annual value of $571.9 million for FY2024, which is 88873.98% up from last year.
  • Latest data reveals that CureVac reported Revenue of $63.3 million as of Q3 2025, which was down 8833.26% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, CureVac's Revenue peaked at $542.4 million during Q3 2024, and registered a low of $939332.8 during Q1 2025.
  • For the 5-year period, CureVac's Revenue averaged around $47.6 million, with its median value being $15.5 million (2024).
  • Per our database at Business Quant, CureVac's Revenue skyrocketed by 292293.77% in 2024 and then plummeted by 9301.17% in 2025.
  • Quarter analysis of 5 years shows CureVac's Revenue stood at $47.1 million in 2021, then tumbled by 74.67% to $11.9 million in 2022, then soared by 103.71% to $24.3 million in 2023, then tumbled by 36.28% to $15.5 million in 2024, then soared by 308.44% to $63.3 million in 2025.
  • Its Revenue was $63.3 million in Q3 2025, compared to $1.4 million in Q2 2025 and $939332.8 in Q1 2025.